How to tackle antimalarial resistance?

27 Dec 2016

Didier Leroy

EMBO Molecular Medicine

DOI: 10.15252/emmm.201607295

Abstract

In the context of drug resistance, malaria is no exception. Even the latest artemisinins have started to lose their full efficacy in patients. Didier Leroy tells us about the strategies adopted by Medicines for Malaria Venture to reduce this terrible culprit.

Read the full article on the EMBO Molecular Medicine website.